![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ARHGEF11 |
Gene summary for ARHGEF11 |
![]() |
Gene information | Species | Human | Gene symbol | ARHGEF11 | Gene ID | 9826 |
Gene name | Rho guanine nucleotide exchange factor 11 | |
Gene Alias | GTRAP48 | |
Cytomap | 1q23.1 | |
Gene Type | protein-coding | GO ID | GO:0001558 | UniProtAcc | O15085 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9826 | ARHGEF11 | CCI_1 | Human | Cervix | CC | 2.19e-06 | 6.44e-01 | 0.528 |
9826 | ARHGEF11 | CCI_3 | Human | Cervix | CC | 1.82e-14 | 8.42e-01 | 0.516 |
9826 | ARHGEF11 | HTA11_3410_2000001011 | Human | Colorectum | AD | 8.20e-04 | -3.10e-01 | 0.0155 |
9826 | ARHGEF11 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.48e-04 | -2.26e-01 | 0.294 |
9826 | ARHGEF11 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 8.81e-05 | -2.88e-01 | 0.3005 |
9826 | ARHGEF11 | F007 | Human | Colorectum | FAP | 6.32e-03 | -3.68e-01 | 0.1176 |
9826 | ARHGEF11 | A015-C-203 | Human | Colorectum | FAP | 1.21e-22 | -3.83e-01 | -0.1294 |
9826 | ARHGEF11 | A015-C-204 | Human | Colorectum | FAP | 4.72e-09 | -3.31e-01 | -0.0228 |
9826 | ARHGEF11 | A014-C-040 | Human | Colorectum | FAP | 8.07e-03 | -3.42e-01 | -0.1184 |
9826 | ARHGEF11 | A002-C-201 | Human | Colorectum | FAP | 5.02e-11 | -3.03e-01 | 0.0324 |
9826 | ARHGEF11 | A001-C-119 | Human | Colorectum | FAP | 6.79e-06 | -4.28e-01 | -0.1557 |
9826 | ARHGEF11 | A001-C-108 | Human | Colorectum | FAP | 9.91e-15 | -3.10e-01 | -0.0272 |
9826 | ARHGEF11 | A002-C-205 | Human | Colorectum | FAP | 4.79e-19 | -4.55e-01 | -0.1236 |
9826 | ARHGEF11 | A015-C-005 | Human | Colorectum | FAP | 2.89e-02 | -1.43e-01 | -0.0336 |
9826 | ARHGEF11 | A015-C-006 | Human | Colorectum | FAP | 3.47e-11 | -3.47e-01 | -0.0994 |
9826 | ARHGEF11 | A015-C-106 | Human | Colorectum | FAP | 3.38e-09 | -2.26e-01 | -0.0511 |
9826 | ARHGEF11 | A002-C-114 | Human | Colorectum | FAP | 5.98e-16 | -4.25e-01 | -0.1561 |
9826 | ARHGEF11 | A015-C-104 | Human | Colorectum | FAP | 1.44e-22 | -3.76e-01 | -0.1899 |
9826 | ARHGEF11 | A001-C-014 | Human | Colorectum | FAP | 2.59e-13 | -3.18e-01 | 0.0135 |
9826 | ARHGEF11 | A002-C-016 | Human | Colorectum | FAP | 2.04e-18 | -3.41e-01 | 0.0521 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00071639 | Cervix | CC | establishment or maintenance of cell polarity | 63/2311 | 218/18723 | 4.25e-11 | 8.76e-09 | 63 |
GO:00510566 | Cervix | CC | regulation of small GTPase mediated signal transduction | 75/2311 | 302/18723 | 1.54e-09 | 1.74e-07 | 75 |
GO:00072656 | Cervix | CC | Ras protein signal transduction | 79/2311 | 337/18723 | 9.49e-09 | 7.77e-07 | 79 |
GO:00300108 | Cervix | CC | establishment of cell polarity | 42/2311 | 143/18723 | 4.30e-08 | 2.62e-06 | 42 |
GO:00160498 | Cervix | CC | cell growth | 92/2311 | 482/18723 | 1.16e-05 | 2.49e-04 | 92 |
GO:00072666 | Cervix | CC | Rho protein signal transduction | 35/2311 | 137/18723 | 1.77e-05 | 3.33e-04 | 35 |
GO:00015588 | Cervix | CC | regulation of cell growth | 77/2311 | 414/18723 | 1.40e-04 | 1.70e-03 | 77 |
GO:0007163 | Colorectum | AD | establishment or maintenance of cell polarity | 77/3918 | 218/18723 | 5.72e-07 | 2.08e-05 | 77 |
GO:0016049 | Colorectum | AD | cell growth | 143/3918 | 482/18723 | 2.83e-06 | 8.09e-05 | 143 |
GO:0001558 | Colorectum | AD | regulation of cell growth | 124/3918 | 414/18723 | 7.67e-06 | 1.86e-04 | 124 |
GO:0007265 | Colorectum | AD | Ras protein signal transduction | 104/3918 | 337/18723 | 1.01e-05 | 2.35e-04 | 104 |
GO:0051056 | Colorectum | AD | regulation of small GTPase mediated signal transduction | 94/3918 | 302/18723 | 1.81e-05 | 3.76e-04 | 94 |
GO:0030010 | Colorectum | AD | establishment of cell polarity | 50/3918 | 143/18723 | 6.90e-05 | 1.11e-03 | 50 |
GO:0007266 | Colorectum | AD | Rho protein signal transduction | 42/3918 | 137/18723 | 4.64e-03 | 3.16e-02 | 42 |
GO:00071632 | Colorectum | MSS | establishment or maintenance of cell polarity | 72/3467 | 218/18723 | 1.90e-07 | 8.30e-06 | 72 |
GO:00300102 | Colorectum | MSS | establishment of cell polarity | 47/3467 | 143/18723 | 2.74e-05 | 5.58e-04 | 47 |
GO:00160492 | Colorectum | MSS | cell growth | 123/3467 | 482/18723 | 7.15e-05 | 1.21e-03 | 123 |
GO:00072651 | Colorectum | MSS | Ras protein signal transduction | 91/3467 | 337/18723 | 7.20e-05 | 1.21e-03 | 91 |
GO:00510561 | Colorectum | MSS | regulation of small GTPase mediated signal transduction | 82/3467 | 302/18723 | 1.31e-04 | 1.99e-03 | 82 |
GO:00015582 | Colorectum | MSS | regulation of cell growth | 105/3467 | 414/18723 | 2.97e-04 | 3.90e-03 | 105 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0513020 | Cervix | CC | Pathogenic Escherichia coli infection | 63/1267 | 197/8465 | 9.28e-10 | 2.00e-08 | 1.19e-08 | 63 |
hsa0516318 | Cervix | CC | Human cytomegalovirus infection | 65/1267 | 225/8465 | 4.59e-08 | 6.47e-07 | 3.83e-07 | 65 |
hsa0492812 | Cervix | CC | Parathyroid hormone synthesis, secretion and action | 27/1267 | 106/8465 | 3.12e-03 | 1.19e-02 | 7.03e-03 | 27 |
hsa05130110 | Cervix | CC | Pathogenic Escherichia coli infection | 63/1267 | 197/8465 | 9.28e-10 | 2.00e-08 | 1.19e-08 | 63 |
hsa0516319 | Cervix | CC | Human cytomegalovirus infection | 65/1267 | 225/8465 | 4.59e-08 | 6.47e-07 | 3.83e-07 | 65 |
hsa0492813 | Cervix | CC | Parathyroid hormone synthesis, secretion and action | 27/1267 | 106/8465 | 3.12e-03 | 1.19e-02 | 7.03e-03 | 27 |
hsa05130 | Colorectum | AD | Pathogenic Escherichia coli infection | 79/2092 | 197/8465 | 1.05e-06 | 1.36e-05 | 8.65e-06 | 79 |
hsa05163 | Colorectum | AD | Human cytomegalovirus infection | 75/2092 | 225/8465 | 2.00e-03 | 1.10e-02 | 7.01e-03 | 75 |
hsa04928 | Colorectum | AD | Parathyroid hormone synthesis, secretion and action | 38/2092 | 106/8465 | 6.60e-03 | 2.77e-02 | 1.76e-02 | 38 |
hsa051301 | Colorectum | AD | Pathogenic Escherichia coli infection | 79/2092 | 197/8465 | 1.05e-06 | 1.36e-05 | 8.65e-06 | 79 |
hsa051631 | Colorectum | AD | Human cytomegalovirus infection | 75/2092 | 225/8465 | 2.00e-03 | 1.10e-02 | 7.01e-03 | 75 |
hsa049281 | Colorectum | AD | Parathyroid hormone synthesis, secretion and action | 38/2092 | 106/8465 | 6.60e-03 | 2.77e-02 | 1.76e-02 | 38 |
hsa051304 | Colorectum | MSS | Pathogenic Escherichia coli infection | 73/1875 | 197/8465 | 1.10e-06 | 1.48e-05 | 9.06e-06 | 73 |
hsa051634 | Colorectum | MSS | Human cytomegalovirus infection | 74/1875 | 225/8465 | 1.12e-04 | 1.01e-03 | 6.19e-04 | 74 |
hsa049284 | Colorectum | MSS | Parathyroid hormone synthesis, secretion and action | 37/1875 | 106/8465 | 1.72e-03 | 9.13e-03 | 5.59e-03 | 37 |
hsa051305 | Colorectum | MSS | Pathogenic Escherichia coli infection | 73/1875 | 197/8465 | 1.10e-06 | 1.48e-05 | 9.06e-06 | 73 |
hsa051635 | Colorectum | MSS | Human cytomegalovirus infection | 74/1875 | 225/8465 | 1.12e-04 | 1.01e-03 | 6.19e-04 | 74 |
hsa049285 | Colorectum | MSS | Parathyroid hormone synthesis, secretion and action | 37/1875 | 106/8465 | 1.72e-03 | 9.13e-03 | 5.59e-03 | 37 |
hsa051308 | Colorectum | FAP | Pathogenic Escherichia coli infection | 62/1404 | 197/8465 | 1.37e-07 | 3.08e-06 | 1.87e-06 | 62 |
hsa051636 | Colorectum | FAP | Human cytomegalovirus infection | 55/1404 | 225/8465 | 1.42e-03 | 7.67e-03 | 4.67e-03 | 55 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ARHGEF11 | SNV | Missense_Mutation | c.1432G>C | p.Asp478His | p.D478H | O15085 | protein_coding | tolerated(0.08) | benign(0.018) | TCGA-Q1-A73P-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ARHGEF11 | SNV | Missense_Mutation | novel | c.3245N>T | p.Ala1082Val | p.A1082V | O15085 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-5M-AATA-01 | Colorectum | colon adenocarcinoma | Unknown | Unknown | I/II | Unknown | Unknown | Unknown |
ARHGEF11 | SNV | Missense_Mutation | rs368227122 | c.1295N>A | p.Arg432Gln | p.R432Q | O15085 | protein_coding | tolerated(0.11) | possibly_damaging(0.903) | TCGA-A6-6654-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
ARHGEF11 | SNV | Missense_Mutation | rs755443263 | c.805N>T | p.Arg269Cys | p.R269C | O15085 | protein_coding | tolerated(0.05) | possibly_damaging(0.857) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
ARHGEF11 | SNV | Missense_Mutation | c.983N>C | p.Lys328Thr | p.K328T | O15085 | protein_coding | deleterious(0.01) | possibly_damaging(0.886) | TCGA-AA-3713-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | 5-fluorouracil | PR | |
ARHGEF11 | SNV | Missense_Mutation | rs768597800 | c.1238N>T | p.Ala413Val | p.A413V | O15085 | protein_coding | deleterious(0) | possibly_damaging(0.865) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
ARHGEF11 | SNV | Missense_Mutation | novel | c.2089N>C | p.Ser697Pro | p.S697P | O15085 | protein_coding | tolerated(0.06) | probably_damaging(0.989) | TCGA-AA-3850-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ARHGEF11 | SNV | Missense_Mutation | rs768597800 | c.1238C>T | p.Ala413Val | p.A413V | O15085 | protein_coding | deleterious(0) | possibly_damaging(0.865) | TCGA-AZ-4615-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | xeloda | PD |
ARHGEF11 | SNV | Missense_Mutation | c.244G>A | p.Gly82Ser | p.G82S | O15085 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ARHGEF11 | SNV | Missense_Mutation | c.136C>T | p.Arg46Cys | p.R46C | O15085 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |